Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants
dc.contributor.author | Pikora, Cheryl A. | |
dc.contributor.author | Sullivan, John L. | |
dc.contributor.author | Panicali, Dennis | |
dc.contributor.author | Luzuriaga, Katherine | |
dc.date | 2022-08-11T08:09:02.000 | |
dc.date.accessioned | 2022-08-23T16:16:28Z | |
dc.date.available | 2022-08-23T16:16:28Z | |
dc.date.issued | 1997-04-07 | |
dc.date.submitted | 2008-11-25 | |
dc.identifier.citation | <p>J Exp Med. 1997 Apr 7;185(7):1153-61.</p> | |
dc.identifier.issn | 0022-1007 (Print) | |
dc.identifier.doi | 10.1084/jem.185.7.1153 | |
dc.identifier.pmid | 9104802 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/34340 | |
dc.description.abstract | High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1-specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1-specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection. | |
dc.language.iso | en_US | |
dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9104802&dopt=Abstract">Link to article in PubMed</a></p> | |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196268/ | |
dc.subject | Cloning, Molecular; Cross Reactions; Disease Progression; Disease Transmission, Vertical; Gene Products, env; Genes, env; HIV Infections; HIV-1; Hematopoietic Stem Cells; Humans; Infant; Infant, Newborn; Polymerase Chain Reaction; T-Lymphocytes, Cytotoxic; Time Factors | |
dc.subject | Life Sciences | |
dc.subject | Medicine and Health Sciences | |
dc.title | Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants | |
dc.type | Journal Article | |
dc.source.journaltitle | The Journal of experimental medicine | |
dc.source.volume | 185 | |
dc.source.issue | 7 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gsbs_sp/988 | |
dc.identifier.contextkey | 672516 | |
html.description.abstract | <p>High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1-specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1-specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection.</p> | |
dc.identifier.submissionpath | gsbs_sp/988 | |
dc.contributor.department | Program in Molecular Medicine | |
dc.contributor.department | Department of Pediatrics | |
dc.contributor.department | Graduate School of Biomedical Sciences | |
dc.source.pages | 1153-61 |